Overview
The Problem
- More than 60% of all chemotherapy patients are incorrectly dosed.
- This is because two patients with the same height and weight are given the same chemotherapy dose even though they may have completely different body composition (as in our example of a Sumo wrestler a Weight lifter).
- One third of chemotherapy patients therefore stop treatment early due to overdosing leading to severe toxicities.
- Incorrect chemotherapy dosing leads to significantly poorer cancer treatment outcomes.
Our Solution
- PredicTx is a validated AI CT image recognition algorithm, trained on cancer patients.
- Provides a comprehensive body composition analysis combined with chemotherapy dosing accuracy.
- Currently we are 3 times more accurate in predicting correct dosing compared to current methods for colorectal cancer.
- Full seamless integration into health systems.
- Clinician centred App providing tailored chemotherapy dosing.
The Benefits
- Guide clinicians on how to accurately dose chemotherapy using an easy to use solution.
- Significantly more patients will be correctly dosed, ensuring that cancer patients have a better chance of a cure.
Why Choose Us?
- Validated AI Model on Australian cancer patients.
- Experienced multidisciplinary team of clinicians, researchers, AI developers, and software integration specialists.
- International competitors are unable to accurately dose chemotherapy.
- There is strong evidence to show that correct first dose of chemotherapy leads to better cancer treatment outcomes.
Our Partners
